Aromatase Inhibitors Compared: Anastrozole vs Letrozole vs Exemestane

You have Anastrozole in a drawer because a forum told you to get some. Week five, your nipples get sensitive, so you take a full milligram. A few days later your joints ache, your libido is gone, and you feel flat. You assume you need more.

You almost certainly need less. Aromatase inhibitors are the most frequently misused ancillary in this space — taken at doses derived from breast cancer protocols, on fixed schedules rather than in response to bloodwork, and often for compounds that do not aromatize at all. This guide covers how the three differ, why crashed estrogen feels like high estrogen, and how to dose one properly.

How Aromatase Inhibitors Work

Aromatase is the enzyme that converts androgens into estrogens. In men it lives mainly in adipose tissue, and it turns a portion of your circulating testosterone into estradiol. On cycle, more testosterone means proportionally more substrate for that enzyme, so estradiol rises alongside it.

An aromatase inhibitor blocks that enzyme. Less conversion, less estradiol.

This is a fundamentally different mechanism from a SERM, and confusing the two causes real problems:

If you have developing gynecomastia right now, a SERM acts directly on breast tissue and is the faster tool. An AI manages the underlying level. They are often used together, and they are not substitutes for one another.

Suicidal vs Competitive Inhibition

The three inhibitors split into two mechanistic classes, and this determines how they behave when you stop.

Competitive (Type II): Anastrozole and Letrozole. These are non-steroidal and bind the aromatase enzyme reversibly. They compete with androgens for the binding site. The enzyme itself is undamaged — when the drug clears, aromatase resumes working immediately. Because your body has been producing extra enzyme to compensate for the blockade, stopping abruptly can produce an estrogen rebound above where you started.

Suicidal (Type I): Exemestane. This is a steroidal compound that binds the enzyme permanently and destroys it. The enzyme must be synthesised anew before conversion resumes. There is no rebound on cessation, because there is no accumulated pool of blocked-but-intact enzyme waiting to be released.

That difference is the strongest practical argument for Exemestane, particularly for anyone who has experienced an estrogen spike after stopping an AI.

The Three Compared

Anastrozole (Arimidex)

The general-purpose default. Roughly 50% suppression makes it forgiving — it is difficult to crash your estrogen with a sensible dose, and the 46-hour half-life means twice-weekly dosing holds levels reasonably steady.

Start at 0.25 mg twice weekly on a moderate testosterone cycle. Many people need less than they assume; plenty of people running 500 mg of testosterone need none at all. The 1 mg tablets found in most packs are a breast cancer dose — split them.

→ Anastrozole 1 mg — Hilma Biocare

Letrozole (Femara)

The strongest of the three by a wide margin. At full clinical dose it suppresses estradiol by up to 98%, which in a man on cycle is far more suppression than you want.

The dose-response curve is extremely steep. The difference between an effective dose and a crashing dose can be a quarter of a tablet, which makes titration genuinely difficult. Most people who report catastrophic estrogen crashes were running Letrozole.

Where it is justified: reversing established gynecomastia, or controlling estrogen on a very high-dose aromatizing cycle where Anastrozole has failed. It is not a first-line AI, and it should not be the one you reach for by default.

→ Letrozole 2.5 mg — Hilma Biocare

Exemestane (Aromasin)

The suicidal inhibitor, and arguably the most sensible choice for most cycles despite being the least commonly used.

Its advantages are structural rather than a matter of potency. No rebound on cessation. A shorter half-life, so a mistake corrects itself faster. And a mildly androgenic active metabolite, which is the likely reason its lipid impact appears to be the gentlest of the three — a real consideration when you are already running compounds that suppress HDL.

Typical dose is 12.5 mg every other day, which is half of a 25 mg tablet.

→ Exemestane 25 mg — Hilma Biocare

Crashed Estrogen: The Trap

This is the section that matters most, because the failure mode is self-reinforcing.

Low estradiol and high estradiol produce overlapping symptoms. Both cause low libido and erectile difficulty. Both can cause fatigue and low mood. So a man with crashed estrogen experiences symptoms he associates with high estrogen, takes more AI, gets worse, and takes more still.

The reliable discriminators are joints and water. Dry, aching joints with a flat, depleted look point to low estrogen. Puffiness with sensitive nipples points to high estrogen. If you have both aching joints and no libido and you are taking an AI, the AI is the problem.

Estrogen is not a nuisance hormone to be minimised. Men need it for bone density, joint health, lipid profile, cognition, mood and sexual function. The goal is a mid-range level, not the lowest number you can achieve.

Recovery from a crash: stop the AI entirely. Levels return over several days to a week, faster with Exemestane than with Letrozole. Do not attempt to correct it by adding anything — simply removing the AI is the fix.

Dose to Response, Not to Schedule

The single most common error is running a fixed protocol — "0.5 mg twice weekly with any cycle" — regardless of dose, compound, body fat or individual aromatase activity.

Aromatase activity varies enormously between people. Body fat percentage is a major driver, since adipose tissue is where most conversion happens. Two men on identical 500 mg testosterone cycles can have completely different estradiol levels, and one may need no AI whatsoever.

A sensible protocol:

1. Start with nothing. Have the AI available but do not take it from day one unless you have a documented history of needing it.
2. Test at week 4–5, once your ester has reached steady state. Sensitive estradiol, total and free testosterone, SHBG.
3. Interpret against symptoms, not just the range. A number above range with no symptoms in a healthy man on cycle does not automatically require intervention.
4. If intervention is needed, start low. Anastrozole 0.25 mg twice weekly, or Exemestane 12.5 mg every other day.
5. Retest after 3–4 weeks. Adjust in small increments.
6. Never double the dose in response to symptoms alone. Test first. The symptoms you are reacting to may be the opposite problem.

The Bloodwork Problem

One technical point that invalidates a great deal of self-management: the standard estradiol immunoassay is unreliable in men.

The common E2 test was designed for women, whose estradiol levels are an order of magnitude higher. At the low concentrations found in men, it cross-reacts with other steroid metabolites and reads inaccurately — usually high. On cycle, with many circulating metabolites present, the error grows.

Ask for sensitive estradiol — often listed as "estradiol, sensitive", "ultrasensitive E2" or LC-MS/MS. It costs slightly more and it is the only version worth acting on.

Men medicating an inflated immunoassay number, crashing their actual estrogen, and feeling terrible is a common and entirely avoidable sequence.

Also test SHBG alongside. Low free testosterone with adequate total testosterone is an SHBG problem, not an estrogen problem, and no amount of AI will fix it.

Which Compounds Actually Need an AI

Only aromatizing compounds convert to estrogen. Running an AI for a compound that does not aromatize achieves nothing except crashing whatever estrogen your base is producing.

Two important exceptions to the right-hand column. First, your testosterone base still aromatizes even when the compound you are focused on does not — a Trenbolone cycle with 250 mg of testosterone still has an estrogen source. Second, Anadrol does not aromatize but is directly estrogenic at the receptor, so an AI will not touch its estrogenic effects; that needs a SERM instead.

And a reminder for the 19-nors: nipple sensitivity on Deca or Trenbolone with in-range estradiol is a prolactin problem, and no AI will help. See the prolactin management guide.

The Cost of the AI Itself

Aromatase inhibitors are treated as free additions to a cycle. They are not — they carry their own side effect profile, and it is driven by the estrogen suppression that is the whole point of taking them.

• Lipids. The most significant cost. Estradiol supports HDL, so suppressing it lowers HDL further on top of whatever your androgens are already doing. On a cycle with a harsh oral, adding an aggressive AI dose compounds an already poor cardiovascular picture. Exemestane appears to be the gentlest of the three here, likely because of its mildly androgenic metabolite.
• Bone mineral density. Estradiol is the primary regulator of bone density in men, not testosterone. Short cycles are not the concern; repeated long-term suppression is a real one, particularly for anyone running AIs on TRT for years.
• Joint health. Estrogen supports collagen synthesis and joint lubrication. Aching, creaking joints are one of the earliest and most reliable signals that you have gone too far.
• Mood and cognition. Low estradiol produces flat affect, anhedonia and difficulty concentrating. This is frequently misattributed to the cycle, to work stress, or to anything other than the tablet causing it.
• Sexual function. Covered above, and worth repeating because it is the symptom most likely to be misread as needing more AI.
• Insulin sensitivity. Some evidence suggests estradiol suppression worsens it, which matters more on a bulk than a cut.

None of this argues against using an AI when bloodwork calls for it. It argues for the minimum effective dose, and against the widespread habit of taking one prophylactically "just in case".

Common Mistakes

• Taking a full 1 mg Anastrozole tablet. That is a breast cancer dose for a woman with no endogenous production to preserve. For a man on cycle it is typically four times what is needed. Split the tablet.
• Starting an AI on day one by default. Estradiol has not risen yet, your ester has not reached steady state, and you are suppressing a hormone that is still at baseline. Wait, test, then decide.
• Increasing the dose in response to symptoms without testing. Since low and high estradiol share symptoms, there is roughly a coin-flip chance you are making it worse.
• Acting on a standard immunoassay result. It over-reads in men. Sensitive estradiol or nothing.
• Running an AI for a non-aromatizing compound. Trenbolone, Winstrol, Masteron and Anavar give it nothing to work on. Your testosterone base may still need it; the other compound does not.
• Using an AI for prolactin symptoms. Different hormone, different pathway, no effect. That needs Cabergoline.
• Stopping a competitive AI abruptly after a long run. Anastrozole and Letrozole can rebound. Taper, or use Exemestane, which does not.
• Chasing a specific estradiol number. There is no universal optimum. Some men feel best at 25 pg/mL, others at 45. Symptoms plus numbers, not numbers alone.

Reversing Existing Gynecomastia

Once glandular tissue has formed, an AI alone will not remove it. Lowering estrogen prevents further growth; it does not reverse what is already there.

The standard approach for established but recent gyno:

• Tamoxifen (Nolvadex) at 20 mg daily — blocks the estrogen receptor directly in breast tissue. This is the primary agent and it is effective on tissue that is still forming.
• An AI alongside to control the underlying level and prevent recurrence.
• Letrozole is sometimes used for aggressive short-term suppression in stubborn cases, then tapered. This is where Letrozole's potency is genuinely useful.
• Time matters. Recent, soft, tender tissue responds. Fibrous tissue established over months or years generally does not, and surgery becomes the only option.

Act early. The window where medication works is measured in weeks, not months.

→ Tamoxifen Citrate — Hilma Biocare

AIs During PCT

Generally, no.

The purpose of PCT is to restart your natural testosterone production, and estrogen has a role in that process. Suppressing it aggressively during recovery works against you: it worsens lipids at a point when they are already poor, it impairs mood and libido when both are already fragile, and it does not accelerate the HPTA restart. SERMs are the correct tool for PCT because they block negative feedback at the hypothalamus without stripping estrogen from the rest of your body.

The exception is a genuine estrogen rebound after stopping a competitive AI, or persistent gyno symptoms carrying into PCT. In those cases a low dose of Exemestane is the reasonable choice, precisely because it does not itself rebound.

Full protocols are in the PCT complete guide, and the symptom picture for high estrogen is covered in high estrogen on cycle.

→ All three aromatase inhibitors, plus Tamoxifen and Clomiphene, are stocked in our PCT category. Every batch is third-party tested.

Frequently Asked Questions

Do I need an AI on every cycle?

No. Plenty of people run moderate testosterone cycles with no aromatase inhibitor and normal bloodwork. Whether you need one depends on your dose, your body fat, your individual aromatase activity and the compounds involved. Have one available, test at week four or five, and take it only if the results and your symptoms both point that way.

Which one should I choose if I am new to this?

Exemestane or Anastrozole. Exemestane has the edge on rebound behaviour and lipids; Anastrozole is more widely documented and easier to find dosing guidance for. Either is a reasonable first choice. Letrozole is not — its dose-response curve is too steep to learn on.

Can I take an AI every day?

You can, and with Exemestane's 24-hour half-life daily or every-other-day dosing is normal. For Anastrozole and Letrozole, half-lives of two days or more mean twice-weekly dosing usually gives steadier levels than daily micro-doses. What matters more than frequency is the total weekly amount and whether bloodwork supports it.

My estradiol is above the reference range but I feel fine. Should I medicate it?

Not automatically. Reference ranges are derived from men not on testosterone. A somewhat elevated estradiol alongside elevated testosterone, with no symptoms, no water retention and no nipple sensitivity, is a common and generally benign finding. Treat symptoms in combination with numbers, not numbers in isolation.

How long does it take to recover from crashed estrogen?

Usually several days to a week after stopping the AI, faster with Exemestane than with Letrozole given the difference in half-life and mechanism. Simply stop taking it. Adding anything else to correct the crash generally makes the picture harder to read.

Can an AI cause hair loss or acne?

Indirectly, yes. Lowering estradiol raises the relative proportion of circulating androgens, which can worsen androgenic side effects in people who are predisposed. It is another reason to aim for a mid-range estradiol rather than the lowest achievable number.

Disclaimer: This content is for informational and harm-reduction purposes only. This does not constitute medical advice. Aromatase inhibitors are prescription medications. Individual results may vary. Consult a qualified healthcare professional before use.